[go: up one dir, main page]

IL125077A0 - Thrombin muteins as antidote for thrombin inhibitors - Google Patents

Thrombin muteins as antidote for thrombin inhibitors

Info

Publication number
IL125077A0
IL125077A0 IL12507797A IL12507797A IL125077A0 IL 125077 A0 IL125077 A0 IL 125077A0 IL 12507797 A IL12507797 A IL 12507797A IL 12507797 A IL12507797 A IL 12507797A IL 125077 A0 IL125077 A0 IL 125077A0
Authority
IL
Israel
Prior art keywords
thrombin
antidote
muteins
inhibitors
thrombin inhibitors
Prior art date
Application number
IL12507797A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL125077A0 publication Critical patent/IL125077A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL12507797A 1996-02-12 1997-02-11 Thrombin muteins as antidote for thrombin inhibitors IL125077A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605126A DE19605126A1 (de) 1996-02-12 1996-02-12 Thrombinmuteine als Antidot für Thrombininhibitoren
PCT/EP1997/000612 WO1997029198A1 (de) 1996-02-12 1997-02-11 Thrombinmuteine als antidot für thrombininhibitoren

Publications (1)

Publication Number Publication Date
IL125077A0 true IL125077A0 (en) 1999-01-26

Family

ID=7785198

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12507797A IL125077A0 (en) 1996-02-12 1997-02-11 Thrombin muteins as antidote for thrombin inhibitors

Country Status (18)

Country Link
US (1) US6060300A (xx)
EP (1) EP0880591A1 (xx)
JP (1) JPH11512621A (xx)
KR (1) KR19990082479A (xx)
CN (1) CN1211280A (xx)
AR (1) AR005797A1 (xx)
AU (1) AU1768497A (xx)
BR (1) BR9707280A (xx)
CA (1) CA2245546A1 (xx)
CO (1) CO4600682A1 (xx)
CZ (1) CZ247798A3 (xx)
DE (1) DE19605126A1 (xx)
HR (1) HRP970077A2 (xx)
HU (1) HUP9900574A2 (xx)
IL (1) IL125077A0 (xx)
NO (1) NO983677D0 (xx)
WO (1) WO1997029198A1 (xx)
ZA (1) ZA971107B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4426722B2 (ja) 1998-05-19 2010-03-03 ケルシウス,エルエルシー フレーム部材と取外し可能に取付けられた膜とを備えたタオルマット
KR20000018933A (ko) * 1998-09-07 2000-04-06 김승수 내피세포 성장억제 활성을 가지는 사람 프로트롬빈 크링글단백질 및 이를 암호하는 유전자
GB2355161B (en) * 1999-10-05 2001-09-12 3Com Corp Network device incorporating selective compression of stored data packets
KR20020008471A (ko) * 2000-07-20 2002-01-31 김승수 내피세포 성장 억제활성을 가지는 인간 프로트롬빈크링글, 그것의 재조합벡터 및 이를 발현하는 재조합 숙주
CN101501216B (zh) * 2006-03-06 2013-10-02 胡玛基因公司 制备重组人凝血酶的方法
KR102069498B1 (ko) 2007-09-28 2020-01-23 포톨라 파마슈티컬스, 인코포레이티드 인자 Xa 저해제에 대한 안티도트 및 그것을 사용하는 방법
MX2011004907A (es) 2008-11-14 2011-07-29 Portola Pharm Inc Antidotos para inhibidores del factor xa y metodos para el uso de los mismos en combinacion con agentes de coagulacion de sangre.
PL3604510T3 (pl) 2009-03-30 2025-07-28 Alexion Pharmaceuticals, Inc. Antidota na inhibitory czynnika xa i sposoby ich stosowania
CN102625712B (zh) 2009-07-15 2017-07-25 博尔托拉制药公司 用于因子xa抑制剂的解毒剂的单位剂量制剂及其使用方法
ES2620421T3 (es) 2009-10-30 2017-06-28 Senova Gesellschaft für Biowissenschaft und Technik mbH Peptidasas acopladas a polímero
AR079944A1 (es) 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante
BR112013025031A2 (pt) 2011-03-30 2017-08-01 Boehringer Ingelheim Int antídotos anticoagulantes
EA037991B1 (ru) 2014-05-26 2021-06-21 Академиш Зикенхёйс Лейден Прогемостатические белки для лечения кровотечений
ES3020087T3 (en) 2020-09-21 2025-05-21 Instr Laboratory Co Detecting and monitoring oral anticoagulants or intravenous direct thrombin inhibitors in a blood sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren

Also Published As

Publication number Publication date
CZ247798A3 (cs) 1999-03-17
AR005797A1 (es) 1999-07-14
ZA971107B (en) 1998-08-11
JPH11512621A (ja) 1999-11-02
EP0880591A1 (de) 1998-12-02
BR9707280A (pt) 1999-07-20
US6060300A (en) 2000-05-09
DE19605126A1 (de) 1997-08-14
NO983677L (no) 1998-08-11
CA2245546A1 (en) 1997-08-14
CN1211280A (zh) 1999-03-17
AU1768497A (en) 1997-08-28
HRP970077A2 (en) 1998-04-30
KR19990082479A (ko) 1999-11-25
CO4600682A1 (es) 1998-05-08
NO983677D0 (no) 1998-08-11
WO1997029198A1 (de) 1997-08-14
HUP9900574A2 (hu) 1999-06-28

Similar Documents

Publication Publication Date Title
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
AU3832895A (en) Thrombin inhibitors
HUP0001848A3 (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
HUP0001826A3 (en) Thrombin inhibitors
IL128664A0 (en) Heterocyclic metalloprotease inhibitors
AU3102397A (en) Metalloprotease inhibitors
PL328307A1 (en) Serinic protease inhibitors
IL128665A0 (en) Bidenatate metalloprotease inhibitors
PL328875A1 (en) Serinic protease inhibitors
IL125077A0 (en) Thrombin muteins as antidote for thrombin inhibitors
PL328223A1 (en) Aspartil protease inhibitors
IL136139A0 (en) Thrombin inhibitors
AU3396697A (en) Thrombin inhibitor
GB9613718D0 (en) Thrombin inhibitors
IL121474A0 (en) Thrombin inhibitors
AU2908197A (en) Thrombin inhibitors
EP1027333A4 (en) THROMBIN INHIBITORS
GB9624292D0 (en) Thrombin inhibitors
GB9625311D0 (en) Thrombin inhibitors
GB9624319D0 (en) Thrombin inhibitors
GB9624278D0 (en) Thrombin inhibitors
GB9605163D0 (en) Thrombin inhibitors
SI0956294T1 (en) Thrombin inhibitors
GB9704209D0 (en) Thrombin inhibitors
GB9716872D0 (en) Thrombin Inhibitors